Search for: "CAMPAIGN/RESPONSIBLE v. FDA" Results 81 - 100 of 150
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2012, 7:42 am by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
3 Feb 2012, 8:28 am by Ken
This is my final response to him to date: Marc: With each communication, you merely supply more evidence in support of everything I have been saying about you. [read post]
1 Feb 2012, 9:15 am by SteinMcewen, LLP
§ 273(c) states that commercial use includes FDA reviews of drug applications, as well as non-commercial use in “nonprofit” or university laboratory “for which the public is the intended beneficiary. [read post]
6 Dec 2011, 1:02 pm by Ken
It is your responsibility to understand when you brake[sic] the law. [read post]
24 Oct 2011, 12:14 pm by Rebecca Tushnet
From the day that anyone learned that tobacco caused disease, the industry engaged in a campaign of deception, undermining government efforts, selling products without regard to social cost. 1600-page decision in US v. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
9 Sep 2011, 8:40 am by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
6 Jun 2011, 6:12 am by Brian A. Comer
“We don’t believe that the dissemination of an FDA- approved package insert constitutes a violation of the South Carolina Trade Practices Act,” Kara Russell, a spokeswoman for Janssen said in an e-mailed statement. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]